Molecular simulations show how drugs block key receptors

Published date 2020-06-24 11:34
Many pharmaceuticals work by targeting what are known as “G-protein-coupled receptors”. In a new study, scientists from Uppsala University describe how they have been able to predict how special molecules that can be used in new immunotherapy against cancer bind to these receptors.

Skriv et svar

Din e-mailadresse vil ikke blive publiceret. Krævede felter er markeret med *